Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 984-989

  Villarreal Jr , Guadalupe ^a,b   Zhang, Yuzhi ^a   Larman, H Benjamin ^a   Gracia Sancho, Jorge ^a   Koo, Andrew ^a   García Cardeña, Guillermo ^a  

^a Laboratory for Systems Biology   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Endothelial cells; KLF2; KLF4; MEK5; Resveratrol; Shear stress

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; KRUPPEL LIKE FACTOR 2; KRUPPEL LIKE FACTOR 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 5; MYOCYTE ENHANCER FACTOR 2; RESVERATROL; SIMVASTATIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEAR STRESS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; VASCULAR ENDOTHELIUM;

ENDOTHELIUM, VASCULAR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MADS DOMAIN PROTEINS; MAP KINASE KINASE 5; MITOGEN-ACTIVATED PROTEIN KINASE 7; MYOGENIC REGULATORY FACTORS; SHEAR STRENGTH; STILBENES;

EID: 73149110581     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.002     Document Type: Article

References (31)

1. Davies P.F. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 75 (1995) 519-560
2. Garcia-Cardena G., and Gimbrone Jr. M.A. Biomechanical modulation of endothelial phenotype: implications for health and disease. Handb. Exp. Pharmacol. (2006) 79-95
3. Pober J.S., and Sessa W.C. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7 (2007) 803-815
4. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352 (2005) 1685-1695
5. Parmar K.M., Larman H.B., Dai G., Zhang Y., Wang E.T., Moorthy S.N., Kratz J.R., Lin Z., Jain M.K., Gimbrone Jr. M.A., and Garcia-Cardena G. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J. Clin. Invest. 116 (2006) 49-58
6. Hamik A., Lin Z., Kumar A., Balcells M., Sinha S., Katz J., Feinberg M.W., Gerzsten R.E., Edelman E.R., and Jain M.K. Kruppel-like factor 4 regulates endothelial inflammation. J. Biol. Chem. 282 (2007) 13769-13779
7. Dekker R.J., Boon R.A., Rondaij M.G., Kragt A., Volger O.L., Elderkamp Y.W., Meijers J.C., Voorberg J., Pannekoek H., and Horrevoets A.J. KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood 107 (2006) 4354-4363
8. Methe H., Balcells M., Alegret Mdel C., Santacana M., Molins B., Hamik A., Jain M.K., and Edelman E.R. Vascular bed origin dictates flow pattern regulation of endothelial adhesion molecule expression. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H2167-H2175
9. Hiroi T., Deming C.B., Zhao H., Hansen B.S., Arkenbout E.K., Myers T.J., McDevitt M.A., and Rade J.J. Proteasome inhibitors enhance endothelial thrombomodulin expression via induction of Kruppel-like transcription factors. Arterioscler. Thromb. Vasc. Biol. 10 (2009) 1587-1593
10. Sen-Banerjee S., Mir S., Lin Z., Hamik A., Atkins G.B., Das H., Banerjee P., Kumar A., and Jain M.K. Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation 112 (2005) 720-726
11. Parmar K.M., Nambudiri V., Dai G., Larman H.B., Gimbrone Jr. M.A., and Garcia-Cardena G. Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J. Biol. Chem. 280 (2005) 26714-26719
12. J. Gracia-Sancho, G. Villarreal, Jr., Y. Zhang, G. Garcia-Cardena, Activation of Sirt1 by resveratrol induces Klf2 expression conferring an endothelial vasoprotective phenotype, Cardiovasc. Res. (2009), doi:10.1093/cvr/cvp337.
13. Bieker J.J. Kruppel-like factors: three fingers in many pies. J. Biol. Chem. 276 (2001) 34355-34358
14. Jiang J., Chan Y.S., Loh Y.H., Cai J., Tong G.Q., Lim C.A., Robson P., Zhong S., and Ng H.H. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat. Cell. Biol. 10 (2008) 353-360
15. Dai G., Kaazempur-Mofrad M.R., Natarajan S., Zhang Y., Vaughn S., Blackman B.R., Kamm R.D., Garcia-Cardena G., and Gimbrone Jr. M.A. Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature. Proc. Natl. Acad. Sci. USA 101 (2004) 14871-14876
16. Comander J., Natarajan S., Gimbrone Jr. M.A., and Garcia-Cardena G. Improving the statistical detection of regulated genes from microarray data using intensity-based variance estimation. BMC Genomics 5 (2004) 17
17. Eccles K.A., Sowden H., Porter K.E., Parkin S.M., Homer-Vanniasinkam S., and Graham A.M. Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow. Atherosclerosis 200 (2008) 69-79
18. Martinez-Gonzalez J., Raposo B., Rodriguez C., and Badimon L. 3-Hydroxy-3-methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: balance between transcriptional and posttranscriptional regulation. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 804-809
19. Wallerath T., Deckert G., Ternes T., Anderson H., Li H., Witte K., and Forstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106 (2002) 1652-1658
20. Xu Q., Hao X., Yang Q., and Si L. Resveratrol prevents hyperglycemia-induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase. Biochem. Biophys. Res. Commun. 388 (2009) 389-394
21. Kato Y., Kravchenko V.V., Tapping R.I., Han J., Ulevitch R.J., and Lee J.D. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16 (1997) 7054-7066
22. Wang X., Merritt A.J., Seyfried J., Guo C., Papadakis E.S., Finegan K.G., Kayahara M., Dixon J., Boot-Handford R.P., Cartwright E.J., Mayer U., and Tournier C. Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway. Mol. Cell. Biol. 25 (2005) 336-345
23. Kinderlerer A.R., Ali F., Johns M., Lidington E.A., Leung V., Boyle J.J., Hamdulay S.S., Evans P.C., Haskard D.O., and Mason J.C. KLF2-dependent, shear stress-induced expression of CD59: a novel cytoprotective mechanism against complement-mediated injury in the vasculature. J. Biol. Chem. 283 (2008) 14636-14644
24. Yan C., Takahashi M., Okuda M., Lee J.D., and Berk B.C. Fluid shear stress stimulates big mitogen-activated protein kinase 1 (BMK1) activity in endothelial cells. Dependence on tyrosine kinases and intracellular calcium. J. Biol. Chem. 274 (1999) 143-150
25. Seyfried J., Wang X., Kharebava G., and Tournier C. A novel mitogen-activated protein kinase docking site in the N terminus of MEK5alpha organizes the components of the extracellular signal-regulated kinase 5 signaling pathway. Mol. Cell. Biol. 25 (2005) 9820-9828
26. Cameron S.J., Abe J., Malik S., Che W., and Yang J. Differential role of MEK5alpha and MEK5beta in BMK1/ERK5 activation. J. Biol. Chem. 279 (2004) 1506-1512
27. Sako K., Fukuhara S., Minami T., Hamakubo T., Song H., Kodama T., Fukamizu A., Gutkind J.S., Koh G.Y., and Mochizuki N. Angiopoietin-1 induces Kruppel-like factor 2 expression through a phosphoinositide 3-kinase/AKT-dependent activation of myocyte enhancer factor 2. J. Biol. Chem. 284 (2009) 5592-5601
28. Segre J.A., Bauer C., and Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 22 (1999) 356-360
29. Wu J., Bohanan C.S., Neumann J.C., and Lingrel J.B. KLF2 transcription factor modulates blood vessel maturation through smooth muscle cell migration. J. Biol. Chem. 283 (2008) 3942-3950
30. Lee J.S., Yu Q., Shin J.T., Sebzda E., Bertozzi C., Chen M., Mericko P., Stadtfeld M., Zhou D., Cheng L., Graf T., MacRae C.A., Lepore J.J., Lo C.W., and Kahn M.L. Klf2 is an essential regulator of vascular hemodynamic forces in vivo. Dev. Cell 11 (2006) 845-857
31. Kuo C.T., Veselits M.L., and Leiden J.M. LKLF: a transcriptional regulator of single-positive T cell quiescence and survival. Science 277 (1997) 1986-1990